Literature DB >> 18692928

Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy.

Martin Hillbrand1, Dietmar Georg, Helmut Gadner, Richard Pötter, Karin Dieckmann.   

Abstract

PURPOSE: Evaluation of dosimetric benefits of advanced radiotherapy techniques for the treatment of abdominal lesions during early childhood. PATIENTS AND METHODS: Treatment planning was performed for five Neuroblastoma (NBL) and four Wilms Tumor (WT) patients. Opposing fields (2F), photon intensity modulated radiotherapy (IMXT) and two proton techniques (passively scattered (PT) and scanned beams (IMPT)) were considered. Averaged dose-volume histograms, associated dosimetric parameters and a radiobiological model for the estimation of the therapy related carcinogenic effect were evaluated.
RESULTS: With respect to the 2F technique, both proton techniques enabled to reduce mean liver and kidney dose by 40-60%; Organ fractions irradiated at the level of the tolerance dose were reduced by 65% for kidneys and 75% for the liver in NBL patients and by additional 10% for WT patients. IMXT enabled to reduce parameters related to the steep high-dose gradient, e.g., V(15Gy) for the kidneys was reduced by a factor 2-3 compared to 2F. V(12Gy) was reduced by 40% in the liver. On the other side, the improvement of those parameters characterizing the low isodose domain was limited for IMXT. The risk for radiation-induced secondary cancer was doubled for IMXT and even more increased for PT if secondary neutrons were taken into account, while this risk remained the same or was reduced by IMPT with respect to 2F.
CONCLUSIONS: Proton beams improved all dosimetric parameters for NBL and WT patients compared to photon techniques. This improvement was limited for IMXT mainly to parameters related to the steep high-dose gradient. Further research is needed to minimize uncertainties for secondary cancer estimations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692928     DOI: 10.1016/j.radonc.2008.06.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  13 in total

1.  PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.

Authors:  J S Kornerup; N P Brodin; T Björk-Eriksson; C Birk Christensen; A Kiil-Berthelsen; M C Aznar; C Hollensen; E Markova; P Munck Af Rosenschöld
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

2.  Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?

Authors:  B Knäusl; C Lütgendorf-Caucig; J Hopfgartner; K Dieckmann; L Kurch; T Pelz; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

3.  A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.

Authors:  Rui Zhang; Rebecca M Howell; Phillip J Taddei; Annelise Giebeler; Anita Mahajan; Wayne D Newhauser
Journal:  Radiother Oncol       Date:  2014-08-12       Impact factor: 6.280

4.  Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.

Authors:  Anne Ducassou; Marion Gambart; Caroline Munzer; Laetitia Padovani; Christian Carrie; Daphne Haas-Kogan; Valérie Bernier-Chastagner; Charlotte Demoor; Line Claude; Sylvie Helfre; Stéphanie Bolle; Julie Leseur; Aymeri Huchet; Hervé Rubie; Dominique Valteau-Couanet; Gudrun Schleiermacher; Carole Coze; Anne-Sophie Defachelles; Aurélien Marabelle; Stéphane Ducassou; Christine Devalck; Virginie Gandemer; Martine Munzer; Anne Laprie
Journal:  Strahlenther Onkol       Date:  2015-04-21       Impact factor: 3.621

Review 5.  Clinical controversies: proton therapy for pediatric tumors.

Authors:  Thomas E Merchant
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

6.  Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma.

Authors:  Sophie Taylor; Pei Lim; Reem Ahmad; Ammar Alhadi; William Harris; Vasilis Rompokos; Derek D'Souza; Mark Gaze; Jennifer Gains; Catarina Veiga
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-09

7.  Proton radiotherapy for solid tumors of childhood.

Authors:  Shane E Cotter; Sean M McBride; Torunn I Yock
Journal:  Technol Cancer Res Treat       Date:  2012-03-15

8.  Can We Spare the Pancreas and Other Abdominal Organs at Risk? A Comparison of Conformal Radiotherapy, Helical Tomotherapy and Proton Beam Therapy in Pediatric Irradiation.

Authors:  Emmanuel Jouglar; Antoine Wagner; Grégory Delpon; Loïc Campion; Philippe Meingan; Valérie Bernier; Charlotte Demoor-Goldschmidt; Marc-André Mahé; Thomas Lacornerie; Stéphane Supiot
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  Assessing a set of optimal user interface parameters for intensity-modulated proton therapy planning.

Authors:  Martin Hillbrand; Dietmar Georg
Journal:  J Appl Clin Med Phys       Date:  2010-08-20       Impact factor: 2.102

10.  Clinical results of proton beam therapy for advanced neuroblastoma.

Authors:  Yoshiko Oshiro; Masashi Mizumoto; Toshiyuki Okumura; Shinji Sugahara; Takashi Fukushima; Hitoshi Ishikawa; Tomohei Nakao; Takayuki Hashimoto; Koji Tsuboi; Haruo Ohkawa; Michio Kaneko; Hideyuki Sakurai
Journal:  Radiat Oncol       Date:  2013-06-12       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.